Filicenol B exhibits potential in pharmaceutical research due to its structural properties that suggest bioactive capabilities. It has been studied for its antimicrobial and antioxidant activities, making it a candidate for development in therapeutic agents. Preliminary studies indicate possible use in inhibiting certain pathogenic microorganisms, particularly in topical formulations. Additionally, its antioxidant profile supports exploration in protective agents against oxidative stress-related conditions. Research is ongoing to evaluate its efficacy and safety for broader medical applications.